Riskpilot← Back to searchSign inGet full accessVITAS AS
ASActiveOrg 968655973Gaustadalléen 21, 0349 OsloDiagnostic imaging services and medical laboratory activities · NACE 8691Est. 199435 employeeswww.vitas.no
Revenue 2025
NOK 89,8M
+16% vs 2024
EBITDA margin
40.7%
+25% vs 2024
Equity ratio
8.2%
Financial strength
Net profit 2025
NOK 28,6M
+24% vs 2024
| Revenue | NOK 89,8M | +16% |
| EBITDA | NOK 36,6M | +25% |
| Net profit | NOK 28,6M | +24% |
| Total assets | NOK 44,2M | +7% |
| Equity | NOK 3,6M | +10% |
| Employees | 35 | — |
Legal name
VITAS AS
Org number
968655973
Legal form
Aksjeselskap
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
10. januar 1994
Share capital
NOK 128 478
Employees
35 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Selskapet er et kommersielt oppdragslaboratorie som har til formål å drive forskning og utvikling, samt leveranse av rasjonelle laboratorie- og kontrolltjenester spesielt innen områdene klinisk kjemi, legemiddel utvikling, bioteknologi, næringsmiddelproduksjon og oljeutvinning
Address
Gaustadalléen 21, 0349 Oslo
Website
www.vitas.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 9 719 | 9 816 | 12 642 | 13 808 | 17 314 | 19 550 | 22 949 | 21 062 | 29 267 | 28 350 | 29 093 | 30 710 | 48 372 | 49 236 | 49 407 | 64 025 | 77 626 | 89 793 |
| Staff expenses | −0 | −4 163 | −5 486 | −4 757 | −6 540 | −8 734 | −10 204 | −11 006 | −10 919 | −13 546 | −14 983 | −14 886 | −15 680 | −19 190 | −21 473 | −22 891 | −26 030 | −27 797 | −30 313 |
| EBITDA | 0 | 2 050 | 487 | 3 839 | 2 453 | 2 718 | 2 890 | 4 511 | 1 849 | 5 422 | 2 816 | 3 287 | 5 027 | 12 404 | 12 206 | 11 788 | 19 725 | 29 256 | 36 571 |
| Depreciation & amort. | −0 | −148 | −158 | −165 | −384 | −579 | −687 | −330 | −229 | −359 | −528 | −542 | −444 | −442 | −478 | −402 | −437 | −464 | −505 |
| EBIT | 0 | 1 902 | 329 | 3 673 | 2 069 | 2 139 | 2 202 | 4 181 | 1 620 | 5 064 | 2 288 | 2 745 | 4 583 | 11 962 | 11 728 | 11 386 | 19 288 | 28 792 | 36 066 |
| Net financials | 0 | 135 | 118 | 131 | 118 | 123 | 246 | 64 | −91 | −27 | 179 | −15 | 26 | −47 | −73 | 289 | −80 | 493 | 599 |
| Profit before tax | 0 | 2 038 | 448 | 3 804 | 2 187 | 2 263 | 2 449 | 4 245 | 1 529 | 5 037 | 2 467 | 2 730 | 4 608 | 11 915 | 11 655 | 11 675 | 19 208 | 29 285 | 36 665 |
| Tax | −0 | 569 | 6 | 686 | 296 | 463 | 525 | 1 021 | 301 | 1 115 | 615 | 511 | 569 | 2 183 | 2 119 | 2 111 | 3 916 | 6 128 | 8 061 |
| Net profit | 0 | 1 468 | 442 | 3 118 | 1 891 | 1 800 | 1 923 | 3 224 | 1 228 | 3 922 | 1 852 | 2 219 | 4 039 | 9 732 | 9 536 | 9 564 | 15 292 | 23 157 | 28 604 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 8 157 | 8 024 | 11 405 | 14 263 | 20 307 | 17 144 | 22 302 | 16 424 | 21 847 | 16 543 | 17 165 | 19 970 | 31 145 | 28 731 | 30 384 | 34 986 | 41 364 | 44 190 |
| Equity | — | 6 083 | 6 104 | 8 441 | 10 863 | 10 867 | 10 790 | 10 790 | 10 790 | 10 978 | 9 136 | 9 136 | 9 149 | 9 298 | 9 307 | 9 344 | 5 393 | 3 281 | 3 620 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 2 074 | 1 920 | 2 964 | 3 401 | 9 441 | 6 354 | 11 513 | 5 635 | 10 869 | 7 407 | 8 029 | 10 821 | 21 846 | 19 424 | 21 040 | 29 593 | 38 083 | 40 570 |
| Total debt | 0 | 2 074 | 1 920 | 2 964 | 3 401 | 9 441 | 6 354 | 11 513 | 5 635 | 10 869 | 7 407 | 8 029 | 10 821 | 21 846 | 19 424 | 21 040 | 29 593 | 38 083 | 40 570 |
EBITDA margin
40.7%
This company
15.8%
Market median
+158% vs market
20072025
Equity ratio
8.2%
This company
38.2%
Market median
-79% vs market
20072025
Return on equity
790.2%
This company
18.4%
Market median
+4195% vs market
20072025
Net profit margin
31.9%
This company
8.1%
Market median
+294% vs market
20072025
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20072025
Debt / equity
11.21×
This company
0.62×
Market median
-1708% vs market
20072025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Dbg As | Company | 24.1% | 24.1% | 2024 |
Redoks As | Company | 22.7% | 22.7% | 2024 |
| Individual | 15.1% | 15.1% | 2024 | |
| Individual | 6.4% | 6.4% | 2024 | |
Teg Holding As | Company | 5.4% | 5.4% | 2024 |
| Individual | 4.0% | 4.0% | 2024 | |
| Individual | 2.3% | 2.3% | 2024 | |
| Individual | 1.9% | 1.9% | 2024 | |
| Individual | 1.6% | 1.6% | 2024 | |
| Individual | 1.3% | 1.3% | 2024 | |
| Individual | 1.3% | 1.3% | 2024 | |
| Individual | 1.2% | 1.2% | 2024 | |
| Individual | 1.0% | 1.0% | 2024 | |
| Individual | 1.0% | 1.0% | 2024 | |
| Individual | 1.0% | 1.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VITAS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tore Odin Bolstad | Board of Directors | 0 companies |
| Thomas Bjellaas | Board of Directors | 0 companies |
| Linni Tiller | Chairman | 0 companies |
| Christian André Drevon | Board of Directors | 0 companies |